News Digest / Ticker: CBIO

Ticker: CBIO

06:12pm, Monday, Aug 11, 2025

Gyre pivots to China commercial pharma; launches Etorel and Contiva, raises cash, revenue dips

Gyre Therapeutics, Inc. (NASDAQ: CBIO) - Quick read on what's happening inside Short version: the company is transitioning from legacy Catalyst operations into a China-focused commercial biopharma (Gyre Pharmaceuticals). It launched two new products in 2025 (Contiva in March, Etorel in June), rai...